0A0D

Alcon Inc.

Healthcare · USD · XETRA

2U3T212

Price

$52.065

-1.82%

Cap

$30.51B

Earnings

30d Trend

-12.5%

0A0D
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityModerate

32% annualised over 90 days

BRAIN47 SIGNAL

0
MODERATE
Risk Level57
Quality66
Momentum42
Technical46
Fundamentals62

Raw weighted: 54×Macro 0.99 (1%)=53

RISK

57/100
90d Volatility
32.1%Moderate
ATR %
2.9%Normal
Max Drawdown (1Y)
-33.5%Volatile

QUALITY

66/100
ROE (avg)
4.5%Weak
Piotroski F-Score
6/9Average
Debt/Equity
0.26Low leverage
Margin Stability
CV 1.1%Very stable
Accruals
-4.3%Cash earnings
Interest Coverage
6.7xAdequate

MOMENTUM

42/100
6-1M Momentum
-8.3%Negative
1M Return
-10.3%Sharp decline
Relative Strength
+1.7% vs sectorIn-line

TECHNICAL

46/100
RSI (14)
36.7Neutral
Price vs SMA200
-15.5%Bearish trend
MACD
+0.34Bullish momentum
Bollinger Band
39%Mid-range
SMA Cross
Golden CrossGolden Cross
Trend Quality (KER)
0.409Mixed

FUNDAMENTALS

62/100
EV/EBIT
22.8Fair
P/FCF
15.7Fair
P/S
2.7Fair
PEG
1.67Fair growth
Shareholder Yield
3.1%Moderate

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months51
3-12 months27
1-5+ years61

Long-term compounder with 3.1% yield

BRAIN47'S ASSESSMENT

I rate Alcon Inc. at 53/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is quality at 66/100. I classify this as a income position with the strongest thesis on a long-term horizon.

PAST PERFORMANCE

1 MONTH

-10.3%

3 MONTHS

-22.3%

12 MONTHS

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Long-term compounder with 3.1% yield. Quality (66) and Fundamentals (62) are the primary strengths. I note that momentum is the weakest area at 42/100 — this warrants monitoring. Historical volatility is moderate at 32%. I classify this as an income position — the 3.1% yield combined with the dividend profile makes it suitable for income generation.

incomeScore: 53/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.